Upload
others
View
90
Download
0
Embed Size (px)
Citation preview
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXX XXXXXXX
ID 15201XX
A THESIS SUBMITTED TO
VIDYASIRIMEDHI INSTITUTE OF SCIENCE AND TECHNOLOGY
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR
THE DEGREE OF MASTER OF ENGINEERING
IN MATERIALS SCIENCE AND ENGINEERING
201X
Title Xxxxxxxxxxxxxx Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxx
Advisor Asst. Prof. Dr. Xxxx Xxxx
Name Ms. Xxxx Xxxx
Program Master of Engineering Program in Biomolecular Science and Engineering
(International Program)
Examination Date XX January 20XX
Vidyasirimedhi Institute of Science and Technology approved this thesis as a partial
fulfillment of the requirements for the degree of Master of Biomolecular Science and
Engineering.
Examination Committee:
…………………………… Chairperson ……………………………… Member
(Asst. Prof. Dr. Rojana Pornprasertsuk) (Asst. Prof. Dr. Xxxxxxxx Xxxxxx)
……………………………… Member ……………………………… Member
(Asst. Prof. Dr. Valerio D’Elia) (Asst. Prof. Dr. Xxxxxxxx Xxxxxx)
……………………………… Member
(Dr. Kanokwan Kongpatpanich)
………………………………………..
(Prof. Dr. Jumras Limtrakul)
Chairperson
Graduate Studies Committee
ii
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Abstract
Xxxxxxxx Xxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx.
Keywords: Two-component catalyst systems, hydrogen bond donors, organocatalysts,
cyclic carbonates, conversion of CO2
iii
Acknowledgement
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxx
XXXXXX XXXXXXX
7 October 2017
iv
Contents
Page
Abstract........................................................................................................................... ii
Acknowledgement ......................................................................................................... iii
List of Tables ................................................................................................................. vi
List of Figures................................................................................................................ vi
List of Abbreviations ...................................................................................................... x
Chapter 1 Introduction .................................................................................................... 2
1.1 O2 as a Raw Material ...................................................................................... 2
1.2 Synthesis of Cyclic Carbonates from CO2 ................................................... 6
1.3 Coupling of CO2 and epoxides by using homogeneous organocatalysts . 6
Chapter 2 Objectives ...................................................................................................... 8
Chapter 3 Literature Reviews ......................................................................................... 9
3.1 Alcohols ............................................................................................................ 9
3.2 Saccharides..................................................................................................... 11
3.3 Silanols ........................................................................................................... 12
3.4 Phenol and derivatives .................................................................................. 12
3.5 Carboxylic acids ............................................................................................ 15
Chapter 4 Materials and Methods................................................................................. 17
4.1 General information ...................................................................................... 17
4.2 Experimental procedures ...................... Error! Bookmark not defined.17
4.2.1 Catalysts screening ............................................................................. 18
4.2.2 Effect of water..................................................................................... 18
4.2.3 Catalytic activity for substrate scope ............................................... 18
4.3 In situ IR experiments and additional catalysis data ................................ 20
4.4 1H NMR investigation of L-ascorbic acid-epichlorohydrin solutions .... 21
Chapter 5 Results and Discussion ................................................................................ 22
5.1 Catalysts screening ........................................................................................ 22
5.2 Effect of water ............................................................................................... 29
5.3 Scope of the Substrate .................................................................................. 30
v
Contents (Cont.)
Page
5.4 The effect of reaction parameters ................................................................ 32
5.5 In situ IR experiments and additional catalysis data ................................ 34
5.6 1H NMR investigation of L-ascorbic acid-epichlorhydrin solutions ...... 37
Chapter 6 Conclusion ................................................................................................... 40
References .................................................................................................................... 42
Appendix ..................................................................................................................... 51
Author’s Biography ...................................................................................................... 52
vi
List of Tables
Table Page
4.1 Chemical Shifts (δ, ppm, CDCl3) for the corresponding
OCH2CHR protons in the epoxides and in the carbonate
products
20
5.1 The screening of several hydrogen bond donors/
nucleophiles dual-organocatalyst for the coupling of CO2
with epichlorohydrin
23
5.2 The catalytic effect of other sugars selection/ TBAI dual-
organocatalyst for the coupling of CO2 with epichlorohydrin
27
5.3 Cycloaddition of CO2 to various substrates catalysed by L-
ascorbic acid, D-fructose, or phenol /TBAI dual
organocatalysts
31
5.4 Cycloaddition of CO2 to various epoxides catalysed by L-
ascorbic acid/TBAI.
33
5.5 Comparison of catalytic activity between L-ascorbic
acid/TBAI and YCl3/TBAI in the presence or in the absence
of water (10 mol%)
36
5.6 Chemical shifts of the protons of L-ascorbic acid and
epichlorohydrin for the spectra presented in Figures 5.8 and
5.9
39
vii
List of Figures
Figure Page
1.1 Several chemical reactions involving CO2 transformation 3
1.2 Synthesis of cyclic carbonate from CO2 and epoxide
cyclization
3
1.1 Synthetic routes to produce cyclic carbonates 4
1.4 Number of publications between 1950 and 2015 for
synthesis of cyclic carbonate in Scifinder
5
1.5 A proposed reaction pathway of bi-component
organocatalysts
7
3.1 Computed free energy surface for glycidol/ CO2 coupling
promoted by TBAB.
9
3.2 Plausible mechanism of the cycloaddition of CO2 in the
presence of vicinal diols.
10
3.3 Plausible mechanism of the cycloaddition of CO2 in the
presence of saccharide/DBU as dual organocatalyst
11
3.4 Plausible mechanism of the cycloaddition of CO2 in the
presence of silanediol/TBAI as dual organocatalyst.
12
3.5 Synthesis of cyclic carbonate from CO2 and terminal
epoxides by using p-methoxyphenol /DMAP as dual
organocatalyst
13
3.6 Synthesis of cyclic carbonate from CO2 and terminal
epoxides catalysed by TBAB in the presence of phenol and
1,2-benzenedio
13
3.7 Schematic structures of tannic acid 14
3.8 Schematic structures of gallic acid 15
3.9 Synthesis of cyclic carbonate from CO2 and terminal
epoxides catalyzed by KI in the presence of HCOOH.
15
viii
List of Figures (Cont.)
Figure Page
3.10 Plausible mechanism of cyclic carbonate from CO2 and
epoxides catalyzed by DMAP in the presence of acetic acid
16
5.1 General organocatalytic activation mechanism for the
synthesis of cyclic carbonate
22
ix
List of Abbreviations
HBD Hydrogen Bond Donor
TBAB Tetra-N-butyl ammonium bromide
TBAI Tetra-N-butyl ammonium iodide
DMAP 4-(dimethylamino)pyridine
DBU 1,8-diazabicyclo [5.4.0]-7-undecene
DABCO 1,4-diazabicyclo [2.2.2] octane
PO Propylene oxide
PC Propylene carbonate
Chapter 1
Introduction
1.1 Heading
The chapter headings should be 14 points and any other titles should be in 12
points. The text in the chapter body should be computer printed in 12 points Times New
Roman font.
1.1.1 Sub-heading 1
Typing should be with a spacing of 1. 5 between lines, including the List
of References and Appendices. Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx.
1.1.1.1 Sub-heading 2
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
1) Xxxxxxxxxxxxxxxxxxxxxxxxxxxx
2) Xxxxxxxxxxxxxxxxxxxxxxxxxxxx
3) Xxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
3
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Chapter 2
Literature Reviews
2.1 The table and figure numbers
The table and figure numbers shall represent the chapter numbers. For example,
the first table in the Chapter 2 shall be “Table 2.1 …………………….”, etc. Number
and title of a table ( Table caption) should be placed ABOVE the table and align left.
The word “Table 2.1” is bold font except its caption.
Table 2.1 .........................................
Header Header Header Header Header
Body
Body
Body
Chapter 3
Methodology and Methods
3.1 Figure
The figure numbers shall represent the chapter numbers. For example, the first
figure in the Chapter 3 shall be “Figure 3.1 ………….”, etc. Number and title of a figure
( Figure caption) should be placed BELOW the figure. For the figure caption which
contains only 1 line, it should align CENTER throughout the thesis. For the figure
caption which contains more than 1 line, it should align left throughout the thesis.
Figure 3.1 Schematic structures of tannic acid
8
Figure 3.2 Number of publications between 1950 and 2015 for synthesis of cyclic
carbonate in Scifinder
9
Chapter 4
Results and Discussion
4.1 Citation
Please follow the VISTEC Vancouver Style for your citation on the thesis.
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
10
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Chapter 5
Conclusion
5.1 Xxxxxxxxxxxxxxxxx
Students have to carefully check your information, language, and format before
submitting to the Graduate Studies. Please follow the process for submitting your
original copy. Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
10
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
11
References
1. Sopeña S, Fiorani G, Martín C, Kleij AW. Highly Efficient organocatalyzed
conversion of oxiranes and CO2 into organic carbonates. ChemSusChem.
2015;8(19):3248-54.
2. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and
management of the vitamin K antagonists. Chest. 2004;126:204S.
3. Bell RG, Caldwell PT. Mechanism of warfarin resistance. Warfarin and the
metabolism of vitamin K1. Biochemistry. 2000;12(9):1759-62.
4. Cai K, Shen W, Ren BY, He J, Wu SZ, Wang W. A phytic acid modified CoFe2O4
magnetic adsorbent with controllable morphology, excellent selective adsorption
for dyes and ultra-strong adsorption ability for metal ions. Chem Eng J.
2017;330:936-46.
5. Coleman WF. Molecular Models of Warfarin and Related Compounds. J Chem
Educ. 2010;87(2):229-.
6. Cui G-H, Wang Z, Yang Y-C, Tian S-W, Yue J. Heterogeneous game resource
distributions promote cooperation in spatial prisoner’s dilemma game. Physica A:
Statistical Mechanics and its Applications. 2018;490:1191-200.
7. Du CF, Xue YT, Wu ZS, Wu ZL. Microwave-assisted one-step preparation of
macadamia nut shell-based activated carbon for efficient adsorption of Reactive
Blue. New J Chem. 2017;41(24):15373-83.
8. Karlsson BCG, Rosengren AM, Andersson PO, Nicholls IA. Molecular insights on
the two fluorescence lifetimes displayed by warfarin from fluorescence anisotropy
and molecular dynamics studies. J Phys Chem B. 2009;113:7945.
9. Krishna KA, Vishalakshi B. Gellan gum-based novel composite hydrogel:
Evaluation as adsorbent for cationic dyes. J Appl Polym Sci. 2017;134(47).
10. Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW. Identification of the
gene for vitamin K epoxide reductase. Nature. 2004;427:541.
11. Mahidol University. Reconfiguring Faculty Roles for Virtual Settings.
2012;73(1):123-40.
12
12. Rosengren AM, Karlsson BCG, Näslund I, Andersson PO, Nicholls IA. In situ
detection of warfarin using time-correlated single-photon counting. Biochem
Biophys Res Commun. 2011;407:60.
13. Sharma V, Chandra F, Sahoo D, Koner AL. Efficient Microwave-Assisted
Synthesis of Sonogashira-Coupled Perylene Monoimide Derivatives: Impact of
Electron-Donating Groups on Optoelectronic Properties. Eur J Org Chem.
2017(46):6901-5.
14. Shi F, Li GX, Zhou ZJ, Xu RD, Li WK, Zhuang WH, et al. Microwave ablation
versus radiofrequency ablation for the treatment of pulmonary tumors. Oncotarget.
2017;8(65):109791-8.
15. Tsuchiya Y, Hamashima Y, Sodeoka M. A New Entry to Pd−H Chemistry:
Catalytic Asymmetric Conjugate Reduction of Enones with EtOH and a Highly
Enantioselective Synthesis of Warfarin. Org Lett. 2000;8(21):4851-4.
16. Unge P, Svedberg LE, Nordgren A, Blom H, Andersson T, Lagerström PO, et al.
A Study of the interaction of omeprazole and warfarin in anticoagulated patients.
Br J Clin Pharmacol. 1992;34:509.
17. Zheng J, Shamsi SA. Combination of Chiral Capillary Electrochromatography with
Electrospray Ionization Mass Spectrometry: Method Development and Assay of
Warfarin Enantiomers in Human Plasma. Anal Chem. 2000;75(22):6295-305.
13
Author’s Biography
Name: XXXXX XXXXXX
Date of birth: February 19th, 1993
Place of birth: Bangkok, Thailand
Current Address: 33/6 Xxxxxxx, Xxxxx, Xxxxxx 12110
Education: Bachelor’s Degree in Chemistry, Thammasat University,
Pathumthani, Thailand (2011-2014)
Master’s degree in Materials Science and Engineering,
Vidyasirimedhi Institute of Science and Technology,
Rayong, Thailand (2015-2017)
Scholarship: Recipient of the full scholarship from Vidyasirimedhi
Institute of Science and Technlogy (VISTEC)
Academic publication: XXXXXX X, Shamsi SA. Combination of Chiral
Capillary Electrochromatography with Electrospray
Ionization Mass Spectrometry: Method Development
and Assay of Warfarin Enantiomers in Human Plasma.
Anal Chem. 2000;75(22):6295-305.